| 000 -LEADER |
|---|
| fixed length control field |
02140nam a2200349 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
Medicina3218 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240401145511.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m||||||||||||||||| |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr||n||||||||n |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220816s2022||||nyu|||||s|||||||||||eng|| |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781264752492 (print-ISBN) |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615/.7 |
| Edition number |
23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Brunton, Laurence L., |
| Relator term |
auth. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Goodman & Gilman |
| 246 30 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Goodman & Gilman, Las bases farmacológicas de la terapéutica, Fourteenth edition |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Fourteenth ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York, N.Y. |
| Name of publisher, distributor, etc |
McGraw-Hill Education LLC. |
| Date of publication, distribution, etc |
c2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource : |
| Other physical details |
ill., figs., tables. |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
McGraw-Hill's AccessMedicina |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and indexes. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
SECTION I: General principles -- CHAPTER 5: Drug Metabolism -- SECTION II: Neuropharmacology -- CHAPTER 12: Anticholinesterase Inhibitors and Reactivators -- CHAPTER 15: 5-Hydroxytryptamine (Serotonin) and Dopamine -- SECTION III: Modulation of Cardiovascular Function 401 -- CHAPTER 29: Drugs Affecting Renal Excretory Function -- Chapter 30: Renin and Angiotensin -- CHAPTER 31: Treatment of Ischemic Heart Disease -- CHAPTER 32: Treatment of Hypertension -- CHAPTER 33: Treatment of Heart Failure -- Chapter 34: Antiarrhythmic Drugs -- CHAPTER 36: Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs -- SECTION VIII: Chemotherapy of neoplastic diseases -- CHAPTER 69: General Principles in Cancer Pharmacotherapy. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
|---|
| Additional physical form available note |
Also issued in Online and PDF version. |
| 588 ## - |
|---|
| -- |
Description based on cover image and table of contents, viewed on August 16, 2022. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Therapeutics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemotherapy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Knollman, Björn C., |
| Relator term |
auth. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Online version : |
| Title |
Goodman & Gilman : Las bases farmacológicas de la terapéutica. |
| Edition |
Fourteenth edition. |
| Place, publisher, and date of publication |
New York, N.Y. : McGraw-Hill Education LLC., |
| Qualifying information |
2022 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
McGraw-Hill's AccessMedicina. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
https://accessmedicina.mhmedical.com/book.aspx?bookid=3218 |
| Link text |
Disponible en AccessMedicina |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
e-book |
